This inventor holds 1 USPTO granted patent. Top assignee: Cellicon Lab Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bo Kyung Park and Antimicrobial Peptide Innovation.
Introduction
Bo Kyung Park is an inventor based in Daejeon, South Korea. His patent work includes research into antimicrobial peptides and their effects on microbial cells.
Latest Patents
Park is associated with 1 patent: “Novel Antimicrobial Peptide with Excellent Microbial Cytoplasm Elution Effect.” The invention concerns an antimicrobial peptide designed to promote the release of microbial cytoplasm.
Career Highlights
Park is associated with Cellicon Lab Inc., a company involved in biotechnology innovation. The available information identifies his patent activity in antimicrobial peptide research.
Collaborations
Park’s listed coworkers include Young Pil Jeong and Won Suk Choi.
Conclusion
Bo Kyung Park’s recorded invention focuses on an antimicrobial peptide with a proposed effect on microbial cells, reflecting his contribution to biotechnology innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile